<DOC>
	<DOCNO>NCT02199795</DOCNO>
	<brief_summary>This small pilot randomize control trial enroll subacute ( &lt; 6 mo ) chronic ( &gt; 6 mo ) stroke survivor ( n=18 total ) dorsiflexion weakness . The subject stratify base interval post-stroke baseline level motor impairment randomize Contralaterally Controlled Neuromuscular Electrical Stimulation ( CCNMES ) versus control . The primary objective study compare effect 6-weeks low extremity CCNMES , apply anti-phase application , motor impairment functional mobility control group ; effect interval post-stroke , subacute ( early ) versus chronic ( late ) post-stroke , assess . The secondary objective determine effect 6-weeks low extremity anti-phase CCNMES functional magnetic resonance imaging ( MRI ) cortical activation pattern use ankle dorsiflexion paradigm . The specific use functional MRI outcome measure explore central mechanism between-group difference . AIM 1 : Determine effect low extremity CCNMES , apply anti-phase application , motor impairment functional mobility hemiparesis compare control group ; ass effect application subacute ( &lt; 6 mo , early ) versus chronic ( &gt; 6 mo , late ) post-stroke period . Hypothesis : Subjects randomize low extremity CCNMES group achieve great improvement motor impairment functional mobility compare control group ; subject subacute post-stroke period achieve great improvement subject chronic post-stroke period . AIM 2 : Demonstrate change functional MRI activation pattern use ankle dorsiflexion paradigm follow low extremity anti-phase CCNMES intervention . Hypothesis : Subjects randomize anti-phase CCNMES group demonstrate change functional MRI cortical activation pattern differs control group ; subject subacute post-stroke period demonstrate change functional MRI activation pattern distinct change note chronic subject . AIM 3 : Define central mechanism post-stroke motor functional recovery associate low extremity anti-phase CCNMES . Hypothesis : Change functional MRI cortical activation pattern follow anti-phase CCNMES intervention correlate change motor impairment functional mobility .</brief_summary>
	<brief_title>Functional Electrical Stimulation Mediated Neuroplasticity : Lower Extremity CCNMES Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<criteria>Age 21 75 year Minimum 2 wks first clinical nonhemorrhagic hemorrhagic stroke Medically stable Unilateral low extremity hemiparesis Ankle dorsiflexor strength â‰¤4/5 Medical Research Council scale , seat NMES paretic ankle dorsiflexors produce ankle dorsiflexion neutral without pain . Full voluntary ROM contralateral ankle Skin intact bilateral low extremity Able NMES system caregiver available assist device need . Able hear respond stimulator auditory cue Able follow 3stage command Able recall 2 3 item 30 minute Cognition communication adequate safe use device base neurological assessment physician principal investigator Severely impaired cognition communication History peroneal nerve injury History Parkinson 's , spinal cord injury , traumatic brain injury , multiple sclerosis Uncontrolled seizure disorder Uncompensated hemineglect ( extinguish double simultaneous stimulation ) Edema paretic low extremity Absent sensation paretic low extremity Evidence deep venous thrombosis thromboembolism History cardiac arrhythmia hemodynamic instability Cardiac pacemaker implant electronic system Botulinum toxin injection low extremity muscle last 3 month Pregnancy Symptomatic peripheral neuropathy Current use psychoactive medication ( except selective serotonin reuptake inhibitor serotoninnorepinephrine reuptake inhibitor antidepressant ) Acetylcholinesterase inhibitor usage Unstable asthmatic condition Metallic implant ( include clip and/or wire ) Prosthetic heart valves Cardiac , renal stent History claustrophobia Low visual acuity Body weight body habitus compatible MRI machine Medical , psychological , social concern identify principal investigator coinvestigator suggest inappropriateness subject participation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>stroke</keyword>
	<keyword>hemiplegia</keyword>
	<keyword>footdrop</keyword>
	<keyword>electrical stimulation</keyword>
</DOC>